| 1 |
32381929 | [A Case of Advanced Hepatocellular Carcinoma Successfully Treated with Liver Resection after Administration of Sorafenib]. | 2020 Mar |
1 |
| 2 |
30171360 | TACE with degradable starch microspheres (DSM-TACE) as second-line treatment in HCC patients dismissing or ineligible for sorafenib. | 2019 Mar |
3 |
| 3 |
31287338 | Comparison of lipiodol infusion and drug-eluting beads transarterial chemoembolization of hepatocellular carcinoma in a real-life setting. | 2019 Jul |
2 |
| 4 |
31367160 | Intermediate-advanced hepatocellular carcinoma in Argentina: Treatment and survival analysis. | 2019 Jul 21 |
1 |
| 5 |
29398869 | Early prediction of survival in hepatocellular carcinoma patients treated with transarterial chemoembolization plus sorafenib. | 2018 Jan 28 |
2 |
| 6 |
29970890 | Novel ADAM-17 inhibitor ZLDI-8 enhances the in vitro and in vivo chemotherapeutic effects of Sorafenib on hepatocellular carcinoma cells. | 2018 Jul 3 |
1 |
| 7 |
26989044 | Concurrent sorafenib therapy extends the interval to subsequent TACE for patients with unresectable hepatocellular carcinoma. | 2016 May |
2 |
| 8 |
27424988 | Transarterial chemoembolization with degradable starch microspheres (DSM-TACE): an alternative option for advanced HCC patients? Preliminary results. | 2016 Jul |
1 |
| 9 |
26734579 | Effectiveness of Sorafenib in Patients with Transcatheter Arterial Chemoembolization (TACE) Refractory and Intermediate-Stage Hepatocellular Carcinoma. | 2015 Dec |
5 |
| 10 |
24350564 | The feasibility of combined transcatheter arterial chemoembolization and radiotherapy for advanced hepatocellular carcinoma. | 2014 May |
1 |
| 11 |
25173458 | TACE plus sorafenib for the treatment of hepatocellular carcinoma: results of the multicenter, phase II SOCRATES trial. | 2014 Nov |
1 |
| 12 |
24393931 | [A case of a patient with hepatocellular carcinoma who achieved long-term survival after repeated transcatheter arterial chemoembolization and sorafenib therapy]. | 2013 Nov |
2 |